Nonsteroideal Anti-inflammatory Drugs (NSAIDs) in clinical practice: managing gastric and cardiovascular risks

For many years, non-steroidal inflammatory drugs (NSAIDs) were commonly used in the treatment of acute pain due to inflammation.With the arrival on the market of NSAIDs with selective action on COX-2 there was a reduction of side effects in the stomach, but not eliminating the possible cardiovascula...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta bio-medica de l'Ateneo Parmense 2013-09, Vol.84 (2), p.98-101
Hauptverfasser: Fanelli, Andrea, Ghisi, Daniela, Fanelli, Guido
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 101
container_issue 2
container_start_page 98
container_title Acta bio-medica de l'Ateneo Parmense
container_volume 84
creator Fanelli, Andrea
Ghisi, Daniela
Fanelli, Guido
description For many years, non-steroidal inflammatory drugs (NSAIDs) were commonly used in the treatment of acute pain due to inflammation.With the arrival on the market of NSAIDs with selective action on COX-2 there was a reduction of side effects in the stomach, but not eliminating the possible cardiovascular complications. The availability of NSAIDs such self-medication can aggravate this type of problem, it is therefore the clinician a fair and accurate assessment of the risk \ benefit based on the characteristics of the individual patient.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1447107166</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1447107166</sourcerecordid><originalsourceid>FETCH-LOGICAL-g151t-655c8809394a2ebf85f216e415a75e73465108605c278d68c9e667601c0990c73</originalsourceid><addsrcrecordid>eNo10LtOwzAYBWAPIFoKr4A8liGSnfgWtqjlUqkqAzBHfx0nMjhOsB2kvj2RKNNZPh0dnQu0JEWZZywnxQJdx_hJiOCc0Su0yBkVnHG1RP4w-JhMGGxjwOHKJ5tZ3zroe0hDOOFtmLqI14e3areN99h6rJ31Vs94DKCT1eYB9-Chs77DHcQUrMbgG6whNHb4gagnBwEHG7_iDbpswUVze84V-nh6fN-8ZPvX592m2mcd5TRl806tFCmLkkFujq3ibU6FYZSD5EYWTHBKlCBc51I1QunSCCEFoZqUJdGyWKH1X-8Yhu_JxFT3NmrjHHgzTLGmjElKJBVipndnOh1709RjsD2EU_3_UfELUMFhJQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1447107166</pqid></control><display><type>article</type><title>Nonsteroideal Anti-inflammatory Drugs (NSAIDs) in clinical practice: managing gastric and cardiovascular risks</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Fanelli, Andrea ; Ghisi, Daniela ; Fanelli, Guido</creator><creatorcontrib>Fanelli, Andrea ; Ghisi, Daniela ; Fanelli, Guido</creatorcontrib><description>For many years, non-steroidal inflammatory drugs (NSAIDs) were commonly used in the treatment of acute pain due to inflammation.With the arrival on the market of NSAIDs with selective action on COX-2 there was a reduction of side effects in the stomach, but not eliminating the possible cardiovascular complications. The availability of NSAIDs such self-medication can aggravate this type of problem, it is therefore the clinician a fair and accurate assessment of the risk \ benefit based on the characteristics of the individual patient.</description><identifier>ISSN: 0392-4203</identifier><identifier>PMID: 24165458</identifier><language>eng</language><publisher>Italy</publisher><subject>Anti-Inflammatory Agents - therapeutic use ; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; Cardiovascular Diseases ; Cyclooxygenase 2 Inhibitors ; Humans ; Risk Factors</subject><ispartof>Acta bio-medica de l'Ateneo Parmense, 2013-09, Vol.84 (2), p.98-101</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24165458$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fanelli, Andrea</creatorcontrib><creatorcontrib>Ghisi, Daniela</creatorcontrib><creatorcontrib>Fanelli, Guido</creatorcontrib><title>Nonsteroideal Anti-inflammatory Drugs (NSAIDs) in clinical practice: managing gastric and cardiovascular risks</title><title>Acta bio-medica de l'Ateneo Parmense</title><addtitle>Acta Biomed</addtitle><description>For many years, non-steroidal inflammatory drugs (NSAIDs) were commonly used in the treatment of acute pain due to inflammation.With the arrival on the market of NSAIDs with selective action on COX-2 there was a reduction of side effects in the stomach, but not eliminating the possible cardiovascular complications. The availability of NSAIDs such self-medication can aggravate this type of problem, it is therefore the clinician a fair and accurate assessment of the risk \ benefit based on the characteristics of the individual patient.</description><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</subject><subject>Cardiovascular Diseases</subject><subject>Cyclooxygenase 2 Inhibitors</subject><subject>Humans</subject><subject>Risk Factors</subject><issn>0392-4203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo10LtOwzAYBWAPIFoKr4A8liGSnfgWtqjlUqkqAzBHfx0nMjhOsB2kvj2RKNNZPh0dnQu0JEWZZywnxQJdx_hJiOCc0Su0yBkVnHG1RP4w-JhMGGxjwOHKJ5tZ3zroe0hDOOFtmLqI14e3areN99h6rJ31Vs94DKCT1eYB9-Chs77DHcQUrMbgG6whNHb4gagnBwEHG7_iDbpswUVze84V-nh6fN-8ZPvX592m2mcd5TRl806tFCmLkkFujq3ibU6FYZSD5EYWTHBKlCBc51I1QunSCCEFoZqUJdGyWKH1X-8Yhu_JxFT3NmrjHHgzTLGmjElKJBVipndnOh1709RjsD2EU_3_UfELUMFhJQ</recordid><startdate>20130901</startdate><enddate>20130901</enddate><creator>Fanelli, Andrea</creator><creator>Ghisi, Daniela</creator><creator>Fanelli, Guido</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20130901</creationdate><title>Nonsteroideal Anti-inflammatory Drugs (NSAIDs) in clinical practice: managing gastric and cardiovascular risks</title><author>Fanelli, Andrea ; Ghisi, Daniela ; Fanelli, Guido</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g151t-655c8809394a2ebf85f216e415a75e73465108605c278d68c9e667601c0990c73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</topic><topic>Cardiovascular Diseases</topic><topic>Cyclooxygenase 2 Inhibitors</topic><topic>Humans</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fanelli, Andrea</creatorcontrib><creatorcontrib>Ghisi, Daniela</creatorcontrib><creatorcontrib>Fanelli, Guido</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Acta bio-medica de l'Ateneo Parmense</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fanelli, Andrea</au><au>Ghisi, Daniela</au><au>Fanelli, Guido</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nonsteroideal Anti-inflammatory Drugs (NSAIDs) in clinical practice: managing gastric and cardiovascular risks</atitle><jtitle>Acta bio-medica de l'Ateneo Parmense</jtitle><addtitle>Acta Biomed</addtitle><date>2013-09-01</date><risdate>2013</risdate><volume>84</volume><issue>2</issue><spage>98</spage><epage>101</epage><pages>98-101</pages><issn>0392-4203</issn><abstract>For many years, non-steroidal inflammatory drugs (NSAIDs) were commonly used in the treatment of acute pain due to inflammation.With the arrival on the market of NSAIDs with selective action on COX-2 there was a reduction of side effects in the stomach, but not eliminating the possible cardiovascular complications. The availability of NSAIDs such self-medication can aggravate this type of problem, it is therefore the clinician a fair and accurate assessment of the risk \ benefit based on the characteristics of the individual patient.</abstract><cop>Italy</cop><pmid>24165458</pmid><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0392-4203
ispartof Acta bio-medica de l'Ateneo Parmense, 2013-09, Vol.84 (2), p.98-101
issn 0392-4203
language eng
recordid cdi_proquest_miscellaneous_1447107166
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Anti-Inflammatory Agents - therapeutic use
Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
Cardiovascular Diseases
Cyclooxygenase 2 Inhibitors
Humans
Risk Factors
title Nonsteroideal Anti-inflammatory Drugs (NSAIDs) in clinical practice: managing gastric and cardiovascular risks
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T15%3A20%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nonsteroideal%20Anti-inflammatory%20Drugs%20(NSAIDs)%20in%20clinical%20practice:%20managing%20gastric%20and%20cardiovascular%20risks&rft.jtitle=Acta%20bio-medica%20de%20l'Ateneo%20Parmense&rft.au=Fanelli,%20Andrea&rft.date=2013-09-01&rft.volume=84&rft.issue=2&rft.spage=98&rft.epage=101&rft.pages=98-101&rft.issn=0392-4203&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E1447107166%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1447107166&rft_id=info:pmid/24165458&rfr_iscdi=true